Adonai N.., Nguyen K.N.., Walsh J.., Iyer M.., Toyokuni T.., Phelps M.E.., McCarthy T.., McCarthy D.W.., Gambhir S.S.2002. Ex vivo cell labeling with 64Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) for imaging cell trafficking in mice with positron-emission tomography. Proc. Natl. Acad. Sci. U.S.A. 99(5):3030–3035.
Article
Allers C.., Sierralta W.D.., Neubauer S.., Rivera F.., Minguell J.J.., Conget P.A.2004. Dynamic of distribution of human bone marrow-derived mesenchymal stem cells after transplantation into adult unconditioned mice. Transplantation. 78(4):503–508.
Article
Benten D.., Cheng K.., Gupta S.2006. Identification of transplanted human cells in animal tissues. Methods Mol. 326:189–201.
Article
Boss W.K. Jr.., Usal H.., Chernoff G.., Keller G.S.., Lask G.P.., Fodor P.B.2000. Autologous cultured fibroblasts as cellular therapy in plastic surgery. Clin. Plast. Surg. 27(4):613–626.
Article
Bulte J.W.., Duncan I.D.., Frank J.A.2002. In vivo magnetic resonance tracking of magnetically labeled cells after transplantation. J. Cereb. Blood Flow Metab. 22(8):899–907.
Article
Cho J.J.., Malhi H.., Wang R.., Joseph B.., Ludlow J.W.., Susick R.., Gupta S.2002. Enzymatically labeled chromosomal probes for in situ identification of human cells in xenogeneic transplant models. Nat. Med. 8(9):1033–1036.
Article
Ferrari A.., Hannouche D.., Oudina K.., Bourguignon M.., Meunier A.., Sedel L.., Petite H.2001. In vivo tracking of bone marrow fibroblasts with fluorescent carbocyanine dye. J. Biomed. Mater. Res. 56(3):361–367.
Article
Fischer U.M.., Harting M.T.., Jimenez F.., Monzon-Posadas W.O.., Xue H.., Savitz S.I.., Laine G.A.., Cox, C.S. Jr.2009. Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cells Dev. 18(5):683–692.
Article
Galbraith D.N.2004. Regulatory and microbiological safety issues surrounding cell and tissue-engineering products. Biotechnol. Appl. Biochem. 40(Pt 1), 35-39. Guerret, S., Govignon, E., Hartmann, D.J. and Ronfard, V. (2003) Longterm remodeling of a bilayered living human skin equivalent (Apligraf) grafted onto nude mice: immuno-localization of human cells and characterization of extracellular matrix. Wound Repair Regen. 11(1):35–45.
Article
Hebda P.A.., Dohar J.E.1999. Transplanted fetal fibroblasts: survival and distribution over time in normal adult dermis compared with autogenic, allogenic, and xenogenic adult fibroblasts. Otolaryngol Head Neck Surg. 121(3):245–251.
Article
Kovacsovics-Bankowski M.., Mauch K.., Raber A.., Streeter P.R.., Deans R.J.., Maziarz R.T.., Van't Hof W.2008. Preclinical safety testing supporting clinical use of allogeneic multipotent adult progenitor cells. Cytotherapy. 10(7):730–742.
Article
Lawrenz B.., Schiller H.., Willbold E.., Ruediger M.., Muhs A.., Esser S.2004. Highly sensitive biosafety model for stem-cell-derived grafts. Cytotherapy. 6(3):212–222.
Article
Lee E.S.., Kwon E.A.., Park J.R.., Kang B.C.., Kang K.S.., Cho M.H.2007. Tumorigenesis study of canine adipose derived-mesenchymal stem cell. J. Toxicol. Pub. Health. 23(3):271–278.
Article
Lee J.H.., Kim Y.K.., Lee S.J.2006. Treatment of Aplasia Cuti Congenita using allogenic dermal matrix and cultured epithelial autograft: A Case Report. J. Korean Soc. Plast. Reconstr. Surg. 33(5):672–675.
Liu L.., Sun Z.., Chen B.., Han Q.., Liao L.., Jia M.., Cao Y.., Ma J.., Sun Q.., Guo M.., Liu Z.., Ai H.., Zhao R.C.2006. Ex vivo expansion and in vivo infusion of bone marrow-derived Flk-1+CD31-CD34- mesenchymal stem cells: feasibility and safety from monkey to human. Stem Cells Dev. 15(3):349–357.
Article
Meyerrose T.E.., De Ugarte D.A.., Hofling A.A.., Herrbrich P.E.., Cordonnier T.D.., Shultz L.D.., Eagon J.C.., Wirthlin L.., Sands M.S.., Hedrick M.A.., Nolta J.A.2007. In vivo distribution of human adipose-derived mesenchymal stem cells in novel xenotransplantation models. Stem Cells. 25(1):220–227.
Article
Moeller F.., Nielsen F.C.., Nielsen L.B.2003. New tools for quantifying and visualizing adoptively transferred cells in recipient mice. J. Immunol. Methods 282(1-2), 73-82. Rubio, D., Garcia-Castro, J., Martin, M.C., de la Fuente, R., Cigudosa, J.C., Lloyd, A.C. and Bernad, A. (2005) Spontaneous human adult stem cell transformation. Cancer Res. 65(8):3035–3039.
Article
Sandulache V.C.., Zhou Z.., Sherman A.., Dohar J.E.., Hebda P.A.2003. Impact of transplanted fibroblasts on rabbit skin wounds. Arch. Otolaryngol. Head Neck Surg. 129(3):345–350.
Article
Schrepfer S.., Deuse T.., Reichenspurner H.., Fischbein M.P.., Robbins R.C.., Pelletier M.P.2007. Stem cell transplantation: the lung barrier. Transplant. Proc. 39(2):573–576.
Article
Seo S.W.., Chang C.H.., Cho M.S.., Hong Y.G.., Jeon S.W.2007. Treatment of partial thickness skin defect with cultured allogenic keratinocytes (Kaloderm.). J. Korean Soc. Traumatol. 20(1):1–5.
Thompson M.., Wall D.M.., Hicks R.J.., Prince H.M.2005. In vivo tracking for cell therapies. Q. J. Nucl. Med. Mol. Imaging. 49(4):339–348.
Trosko J.E.., Tai M.H.2006. Adult stem cell theory of the multi-stage, multi-mechanism theory of carcinogenesis: role of inflammation on the promotion of initiated stem cells. Contrib. Microbiol. 13:45–65.
Article
Vilalta M.., Degano I.R.., Bago J.., Gould D.., Santos M.., Garcia-Arranz M.., Ayats R.., Fuster C.., Chernajovsky Y.., Garcia-Olmo D.., Rubio N.., Blanco J.2008. Biodistribution, longterm survival, and safety of human adipose tissue-derived mesenchymal stem cells transplanted in nude mice by high sensitivity non-invasive bioluminescence imaging. Stem Cells Dev. 17(5):993–1003.
Article
Watson D.., Keller G.S.., Lacombe V.., Fodor P.B.., Rawnsley J.., Lask G.P.1999. Autologous fibroblasts for treatment of facial rhytids and dermal depressions. A pilot study. Arch. Facial Plast. Surg. 1(3):165–170.
Article
Yoon S.H.., Shim J.S.., Jung J.M.., Park D.H.., Song C.H.2008. The usefulnesss of cultured allogenic keratinocyte for burn treatment. J. Korean Soc. Plast. Reconstr. Surg. 35(4):413–418.